Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT03078023
Are we able to use the EPO staining technique using the sponge ?
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
EPO staining on esophageal sponge samples had a strong association with peak esophageal eosinophil counts on endoscopic biopsy specimens in a small study of 26 patients Using a cut-off of 1.1 absorbance units in a colorimetric assay at a wavelength of 492nm the EPO stain had sensitivity and specificity of 1105 and 83% respectively for a peak eosinophil count of 15 eos/hpf on histologic endoscopic obtained biopsy specimens. The technique of EPO staining is standardized and can be completed in 45 minutes time. Currently, we have found esophageal sponge cytology sensitive and specific for assessment of esophageal eosinophilia. It allows disease activity assessment without endoscopy is much preferred by patients over the standard endoscopic technique of disease assessment. The process of specimen preparation in fairly tedious and interpretation takes significant experience. If EPO staining on non-endoscopic esophageal sponge studies was accurate at assessing disease activity, this is a tool that could be easily performed and interpreted with a rapid turnaround time.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Swallowed sponge: Subjects having a clinical upper endoscopy will be asked to swallow the sponge 2 hours prior to EGD
Other names: brush
Time frame: 1 year
Patients will swallow the sponge prior to a clinical upper endoscopy with biopsies. We will compare upper endoscopy biopsies to the pathology from the cytosponge using the EPO staining technique.
Mayo Clinic
Other
Is EPO Staining on Esophageal Sponge Samples a Simple Reliable Method of Accessing Esophageal Eosinophilia?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06501274
Digestive System Diseases, Eosinophilia
Stevenage, Hertfordshire, United Kingdom
View Trial DetailsNCT01988285
Digestive System Diseases, Eosinophilia
Chapel Hill, North Carolina, United States
View Trial DetailsNCT07093008
Digestive System Diseases, Eosinophilia
Madison, Wisconsin, United States
View Trial DetailsNCT05774184
Digestive System Diseases, Eosinophilia
Birmingham, Alabama, United States
View Trial Details